Company disposed the business. Company is in advanced stage of negotiation to diversify and take over a sick companyBackground The Chemo Pharma Laboratories Limited was established in 1942 and has been making pharmaceuticals and diversified into bulk drugs. However due to increase in competition and flow of new drugs, Company...
STARSOURCE MULTITRADE LIMITED (formerly Chemo Pharm Laboratories Limited) has confirmed it is exempt from certain corporate governance requirements. This is because its paid-up equity capital is ₹1.5 Cr and net worth was ₹13.14 Cr as of the last financial year, both falling below the regulatory thresholds of ₹10 Cr and...
STARSOURCE MULTITRADE LIMITED has confirmed its adherence to share transfer and dematerialization norms for the recent quarter. The company's Registrar and Share Transfer Agent verified that all requests for converting physical shares into electronic form were properly processed, accepted or rejected, and subsequently listed. Physical certificates were cancelled, and corresponding...
Chemo Pharma Laboratories Limited has officially changed its corporate name to Starsource Multitrade Limited. This important identity shift received approval from the Registrar of Companies, leading to necessary amendments in the company's Memorandum and Articles of Association. For investors and all stakeholders, this means the company will now be known...
Chemo Pharma Laboratories has announced the closure of its trading window for designated persons, including promoters, directors, and employees, starting from the beginning of October. This closure is ahead of the upcoming financial results for the quarter. The trading window will remain closed until two clear trading days after these...
Chemo Pharma Laboratories' shareholders have approved significant changes at their Annual General Meeting. Mr. Ruchit Mehta was appointed as Managing Director & CEO, and Mr. Utsav Trivedi as Executive Director & CFO. Additionally, Ms. Sarvagya Goel, Ms. Shilpy Chopra, and Ms. Simran Utsav Trivedi were appointed as Independent Directors. The...
